nach oben

Erschienen in:

2010 | OriginalPaper | Buchkapitel

12. Pharmaceutical Waste: The Patient Role

verfasst von : Staffan Castensson, Anders Ekedahl

Erschienen in: Green and Sustainable Pharmacy

Verlag: Springer Berlin Heidelberg

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

The manufacture and use of pharmaceuticals will always be connected with the generation of various categories of waste containing active pharmaceutical ingredients (APIs) and excipients, their transformation products and unwanted by-products. The release of these often highly biologically active chemicals into the environment must be controlled to prevent unacceptable consequences to the environment or to people’s health.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Vorheriges Kapitel Disposal of Pharmaceutical Waste in Households – A European Survey

Nächstes Kapitel Forecast of Pharmaceutical Consumption in the Netherlands Using Demographic Projections

Abahussain EA, Ball DE (2007) Disposal of unwanted medicines from households in Kuwait. Pharm World Sci 29, 368–373CrossRef

Abahussain EA, Ball DE, Matowe WC (2006) Practice and opinion towards disposal of unused medication in Kuwait. Med Princ Pract 15, 352–357CrossRef

Agness S (2002) Kasserade läkemedel och attityder hos apotekskunder till provförpackningar och synonympreparat. [Disposal of drugs and attitudes of pharmacy customers to trial packages and synonymous drugs] Report Apoteket AB 2002-01-20

Bäckström I, Olme B (1997) Projekt Compliance – Orsak, struktur och volym av återlämnade läkemedel till apoteken. [Project Compliance – Reasons, structure and volume of drugs returned to pharmacies]. Project report. Apoteket AB June 1997

Blom AT, De Bruijn JC, Van de Vaart FJ (1996) How consumers deal with the remainders of unused prescription drugs. Pharmaceutisch Weekblad 131, 102–107

Boije C (2001) Marknadsundersökning. Överbliven receptbelagd medicin. [Market research. Unused prescriptions drugs] 2001-02-22. SIFO Research & Consulting

Boije C (2004) Överbliven receptbelagd medicin. [Unused prescriptions drugs]. Gullers/LIF, SIFO Research International Sweden AB. Pnr 1511677. January 2004

Boije C (2007) Överbliven receptbelagd medicin. [Unused prescriptions drugs]. Gullers/LIF, SIFO Research International Sweden AB. Pnr 1515648. January 2007

Bound JP, Voulvoulis N (2005) Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United Kingdom. Environ Health Perspect 113, 1705–1711CrossRef

Braund R, Chuah F, Gilbert R, Gn G, Soh A, Yin Tan L, Shing Tiong H, Yuen Y-C (2008) Identification of the reasons for medication returns. NZ Fam Physician 35, 248–252. [cited 2008 Dec 04]. Available from: http://rnzcgp.org.nz/assets/Uploads/NZFP/Aug2008/Braund_Aug_08.pdf

Braybrook S, John DN, Leong K (1999) A survey of why medicines are returned to pharmacies. Pharm J [serial on the Internet] 263, 7063. [cited 2008 Oct 10]. Available from: http://www.pharmj.com/editorial1999/19990918/pharmacypractice/braybrook2.html

Bronder E, Klimpel A (1992) Der Rucklauf unverbrauchter Arzneimittel. [The return of unused drugs]. Pharm Z 137, 554–556

Bronder E, Klimpel A (2001) Unused drugs returned to the pharmacy – new data. Int J Clin Pharmacol Ther 39, 480–483

Carter BA, Coppens RC (1996) EnviR research project on drug waste in Alberta. Summary report. Alberta Pharmaceutical Association

Castensson S (2008) Pharmaceutical waste. In: Kümmerer K (ed.) Pharmaceuticals in the Environment. Sources, Fate, Effects and Risks. 3rd edition, Springer, Berlin, Heidelberg, New York, pp. 551–561

Collins L (2001) The Waste Medicines Survey. CherwellVale Pharmacy Development Group

Coma A, Modamio P, Lastra CF, Bouvy ML, Marino EL (2008) Returned medicines in community pharmacies of Barcelona, Spain. Pharm World Sci 30, 272–277CrossRef

Compas (2002) F&DA Environmental Assessment Regulations Project Benchmark Survey. A Report to Health Canada (POR-02-13), Office of Regulatory and International Affairs. March 2002. Ottawa, Toronto, Winnipeg: Compas Inc. (PN: 332-04). [cited 2008 Oct 10]. Available from: http://www.hc-sc.gc.ca/ewh-semt/contaminants/person/impact/por-02-13-eng.php

Cook H (1996) Why so many drugs go to waste. Pharm Pract 6, 268, 270

Credé B (1995) How much unused medication was collected by Community Pharmacies in Barking and Havering in 1994/95. Report Barking and Havering Health Authority, The Clockhouse, East St, Barking IG11 8EY

Cromarty E (1998) A review of drug wastage in primary care. Report October 1998. Grampian Area Pharmaceutical Committee, United Kingdom

Cyclamed [homepage on the Internet]. [cited 2008 Oct 1]. Available from: http://www.unpf.org/cyclamed/video_index2.htm

Daughton CG (2003) Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. II. Drug disposal, waste reduction, and future directions. Environ Health Perspect 111, 775–785CrossRef

Daughton CG, Ruhoy IS (2008) PharmEcovigilance: Aligning pharmacovigilance with environmental protection. In: Rahman SZ, Shahid M, Gupta V (eds.) An Introduction to Environmental Pharmacology. Ibn Sina Academy, Aligarh, India, pp. 21–34. [cited 2009 June 12]. Available from: http://www.epa.gov/nerlesd1/bios/daughton/IntroEnvironPharmacol-Chapter1-2008.pdf

D.U.M.P. (1997) Report on the Buckinghamshire D.U.M.P. (Dispose of Unwanted Medicines and Pills) Campaign October 1997. Buckinghamshire Health Authority, Aylesbury, Bucks, United Kingdom

ECON (2002) Kassasjon av legemidler. [Dispose of drugs]. ECON-rapport nr. 41/02. Prosjekt nr. 36520. 14. May 2002. ISBN 82-7645-525-5. [cited 2008 Oct 7]. Available from: http://www.econ.no/stream_file.asp?iEntityId=1225

Ekedahl A (2003) Unused drugs returned to pharmacies – a few patients return a large proportion of unused drugs. J Soc Adm Pharm 20, 257–258

Ekedahl A (2006) Reasons why medicines are returned to Swedish pharmacies unused. Pharm World Sci 28, 352–358CrossRef

Ekedahl A, Wergeman L, Rydberg T (2003) Unused drugs in Sweden measured by returns to pharmacies. J Soc Adm Pharm 20, 26–31

Essential Services: Waste Management. [cited 2008 Oct 1]. Available from: http://www.psnc.org.uk/pages/essential_services_waste_management.html

Garey KW, Johle ML, Behrman K, Neuhauser MM (2004) Economic consequences of unused medications in Houston, Texas. Ann Pharmacother 38, 1165–1168CrossRef

Gehler Mariacher G, Rota M, Hersberger KE (1998) Rücklauf ungenutzter Medikamente in Apotheken [Return of unused drugs to pharmacies]. Schweiz Rundsch Med Prax 87, 1441–1443

Götz K, Keil F (2007) Medikamentenentsorgung in privaten Haushalten: Ein Faktor bei der Gewässerbelastung mit Arzneimittelwirkstoffen? [Drug disposal in private households: Does the disposal of pharmaceuticals via domestic sanitary devices contribute to water contamination?] USWF – Z Umweltchem Ökotox 19, 180–188. doi:10.1065/uwsf2007.07.201

Grainger-Rousseau T-J, Fielding DW, Smith MA, Daws D, Desrosiers D (1999) What’s left in the medicine cabinet? The BC EnviRx Project. Poster No. 296. International Congress on Clinical Pharmacy, Orlando, FL April, 1999

Grant P (2001) Return of waste medicines to a community pharmacy. Prescriber 12, 29–38

Hawksworth GM, Wright DJ, Chrystyn H (1996) A detailed analysis of the day to day unwanted medicinal products returned to community pharmacies for disposal. J Soc Adm Pharm 13, 215–222

Heeke A, Günther J (1993) Arzneimittel im Müll. Eine studie der AOK Essen über nicht verbrauchte Arzneimittel. Deutsche Apotheker Zeitung 133, 4331–4337

Hepburn T, et al. (1997) Survey of unwanted medicines returned to pharmacies. Ayrshire & Arran Primary Care Drug and Therapeutics Committee. Ayrshire and Arran Health Board. Report January 1997

Herring ME, Shah SK, Shah SK, Gupta AK (2008) Current regulations and modest proposals regarding disposal of unused opioids and other controlled substances. J Am Osteopath Assoc 108, 338–343

Illinois-Indiana Sea Grant. Habitats and Ecosystems [homepage on the Internet]. Disposal of Unwanted Medicines: A Resource for Action in Your Community. Introduction. [cited 2008 Aug 27]. Available from: http://www.iisgcp.org/unwantedmeds/index.htm http://www.iisgcp.org/unwantedmeds/updatedToolKitMaterials/1.0Introduction.pdf

Isacson D, Olofsson C (1999) Drugs up in smoke: a study of caseated drugs in Sweden. Pharm World Sci 21, 96–99CrossRef

Jones I, Britten N (1998) Why do some patients not cash their prescriptions. Br J Gen Pract 48, 903–905

Jonsson J (2000) Bortkastade pengar – en studie av kasserade läkemedel. [Wasted money – a studie of drugs disposed of] Apoteksgrupp Norrbotten, Norrbottens läkemedelskommitté 2000-04-16

Kallaos J, Wheeler K, Wong C, Zahller M (2007) Pharmaceuticals in wastewater streams: Disposal practices and policy options in Santa Barbara. [cited 2008 Aug 27]. Available from: http://www.bren.ucsb.edu/research/documents/Phar maceuticalsFinalReport.pdf

Kolar J, Chybova L, Holecko D (2001) [Unused drugs returned to pharmacies. I]. Ceska Slov Farm 50, 181–187

Kuspis DA, Krenzelok EP (1996) What happens to expired medications? A survey of community medication disposal. Vet Hum Toxicol 38, 48–49

Langley C, Marriott J, Mackridge A, Daniszewski R (2005) An analysis of returned medicines in primary care. Pharm World Sci 27, 296–299CrossRef

Larsson DGJ, De Pedro C, Paxéus N (2007) Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J Haz Mat 148, 751–755CrossRef

Linton A (2003) Why Waste? Campaign Review of Drug Wastage in Antrim/Ballymena Locality. Report March 2003, Northern Health and Social Services Board, Northern Ireland

Longmore RB, Sunderland VB, Sansom LN (1995) Analysis of a “Medidump” campaign in Australia. Int J Pharm Pract 3, 186–191CrossRef

Lynch JC, McCullough T (2008) The Collection and Disposal of Waste Medications. US Pharm [serial on the Internet] 33, HS-20–HS-24. [cited 2008 Aug 27]. Available from: http://www.uspharmacist.com/index.asp?show=article&page=8_2302.htm

Lægemiddelstyrelsen (2003) Hamstring af lægemidler i det behovsafhængige tilskudssystem. [Hoarding of drugs within the need dependent public insurance system]. Lægemiddelstyrelsen, Denmark 1 Apr 2003

Lægemiddelstyrelsen/Danmarks Apotekerforening (2001) Returmedicin på apotekerne. [Medicine return at pharmacies]. København, Denmark November 2001

Macarthur D (2000) Any old drugs? Two schemes for the disposal of unwanted medicines in Europe. Pharm J [serial on the Internet] 264, 223–224. [cited 2008 Aug 27]. Available from: http://www.pharmj.com/editorial/20000205/articles/olddrugs.html

Mackridge AJ, Marriott JF (2006) Unused medicines in primary care: a postal questionnaire. Int J Pharm Pract 14(S1), A23–A24

Mackridge AJ, Marriott JF (2007) Returned medicines: waste or a wasted opportunity? J Public Health 29, 258–262CrossRef

Marchiset-Ferlay N, Gerbaud L, Sauvant MP, et al. (2001) [Description of unused drugs collected in pharmacies in the Puy-de-Dome region in France]. Rev Epidemiol Sante Publique 49, 551–558

McGovern EM, Tennant S, Mackay M (2002) Audit of returned medicines to community pharmacy. Pharm World Sci 24, A11–A12.

Medications Return Program [homepage on the Internet]. [cited 2008 Oct 1]. Available from: http://www.medicationsreturn.ca/

Metzger JW (2004) Drugs in municipal landfills and landfill leachates. In: Kümmerer K (ed.) Pharmaceuticals in the Environment. Sources, Fate, Effects and Risks. 2nd edition, Springer, Berlin, Heidelberg, New York, pp. 133–137CrossRef

Nguyen A, Tzianetas R, Louie S (2002) Responsible drug disposal program in North Vancouver. CMAJ 166, 1252–1253

Paterson JM, Anderson GM (2002) “Trial” prescriptions to reduce drug wastage: Results from Canadian programs and a community demonstration project. Am J Manag Care 8, 151–158

Phillips M, Allanson H, Shamsuddin T (1995) A survey of medicines returned to community pharmacists for disposal. Report Lancashire FHSA July 1995

RUM (Returning Unwanted Medicine) [homepage on the Internet]. [cited 2008 Oct 1]. Available from: http://www.returnmed.com.au/

Seehusen DA, Edwards J (2006) Patient practices and beliefs concerning disposal of medications. J Am Board Fam Med [serial on the Internet] 19, 542-547. [cited 2008 Aug 27]. Available from: http://www.jabfm.org/cgi/content/abstract/19/6/542

Sigre [homepage on the Internet]. [cited 2008 Oct 1]. Available from: http://www.sigre.es/farmacias_en_SIGRE.asp

Socialstyrelsen (2004) [Swedish National Board of Health and Welfare] Kasserade läkemedel. Förslag på åtgärder för att minska mängden överblivna läkemedel. [Discarded drugs. Suggested measures for reducing the amount of leftover drugs]. [cited 2008 Oct 30]. Available from: http://www.socialstyrelsen.se/Publicerat/2004/8474/2004-103-12.htm

Sullivan MJ, George CF (1996) Medicine taking in Southampton: a second look. Br J Clin Pharmacol 42, 567–571

Thormodsen M, Fonneløp H, Rytter E, Tørisen HM (1997a) Medisinretur som kvalitetsindikator for farmakoterapien – hva blir til overs? [Returned medicines as quality indicator for pharmacotherapy – what is left?]. Tidsskr Nor Laegeforen [serial on the Internet] 117, 3517–3520. [cited 2008 Oct 10]. Available from: http://ww2.tidsskriftet.no/tsweb/199724/art10.html

Thormodsen M, Fonneløp H, Rytter E, Tørisen HM (1997b) “Brukes etter avtale med legen” –årsaker til at pasienten får medisin til overs. [“To be used as directed by your doctor” – reasons why patients end up with unused medication]. Tidsskr Nor Laegeforen [serial on the Internet] 117, 3521–3525. [cited 2008 Oct 10]. Available from: http://ww2.tidsskriftet.no/tsweb/199724/art11.html

Valormed [homepage on the Internet]. [cited 2008 Oct 1]. Available from: http://www.valormed.pt

Wold G, Hunskår S (1992) Bruk og kast av medikamenter i hjemmet. Erfaringer fra en kommunal innsamlingsaksjon. [Use and disposal of drugs at home. Experiences of a community campaign for drug collection]. Tidsskr Nor Laegeforen 112, 1605–1607

Woolf M, Scott D (1995) Residual Medicines. OPCS Omnibus Survey Publications, Report 4. HM Stationery Office, London

Zimmer A, Graeser U, Wakolbinger A, Kreuter J (1999) Hessische Apotheken entsorgen jährlich 6 Millionen. Pharmazeutische Zeitung (PZ) [serial on the Internet] 03/1999. [cited 2008 Oct 8]. Available from: http://www.pharmazeutische-zeitung.de/fileadmin/pza/1999-03/pharm4.htm and Zimmer A, Graeser U, Wakolbinger A, Kreuter J (1999) Altarzneimittelstudie: Rücklauf von Altarzneimitteln in hessischen Apotheken. Pharmazeutische Zeitung (PZ) 144, 23–30. [cited 2008 Oct 8]. Available from: http://www.kfunigraz.ac.at/pharmazie/pharmtech/docs/zimmer_12.pdf

Zimmer A, Zimmer AK, Kreuter J (1992) Rücklauf von Alt-Arzneimitteln in Apotheken. Pharmazeutische Zeitung (PZ) 137, 20–29

Titel: Pharmaceutical Waste: The Patient Role
verfasst von: Staffan Castensson
Anders Ekedahl
Verlag: Springer Berlin Heidelberg
Buch: Green and Sustainable Pharmacy
Print ISBN: 978-3-642-05198-2

Electronic ISBN: 978-3-642-05199-9

Copyright-Jahr: 2010
DOI: https://doi.org/10.1007/978-3-642-05199-9_12